Skip to content

Effect of neuromagnetic regulation on rehabilitation in patients with nerve displacement after ischemic stroke: a randomized controlled trial.

Effect of neuromagnetic regulation on rehabilitation in patients with nerve displacement after ischemic stroke

Status
Recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2000036207
Enrollment
Unknown
Registered
2020-08-21
Start date
2020-09-01
Completion date
Unknown
Last updated
2020-09-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

stroke

Interventions

control group:Pseudo stimulation routine rehabilitation
experimental group:TMS stimulation + routine rehabilitation

Sponsors

Yueyang Hospital of Intergrated Tradition Chinese and Western Medicine Shanghai University of Traditional Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: 1. Patients with ischemic stroke diagnosed by clinical assessment and comprehensive imaging examination meet the diagnostic criteria of ischemic stroke; 2 Fugl-meyer Motor function score confirmed motor dysfunction; 3. 18-70 years of age, male and female; 4. No cognitive impairment or communication impairment, simple intelligence state examination (mmse) more than 27 points; Patients after nerve displacement.

Exclusion criteria

Exclusion criteria: 1. Patients with severe systemic diseases such as cardiopulmonary diseases who can not tolerate rehabilitation; 2. Persons with a family history of psychosis, major depression (suicidal tendency) or epilepsy diagnosed; 3. The existence of diabetes, uremia and other serious systemic diseases; 4. Severe joint contracture; 5. Any cause of disturbance of consciousness; 6. There are contraindications for transcranial direct current/magnetic stimulation (tms/tdcs) and functional magnetic resonance (fmri) tests according to safety guidelines in the body or other implanted electronic devices, according to safety guidelines; 7. Hearing or visual impairment may affect assessment and treatment; 8. Use drugs that alter the excitability of the cerebral cortex (antiepileptic, sedative, hypnotic, etc).

Design outcomes

Primary

MeasureTime frame
Changes of Fugl Meyer motor function score of affected upper limb;

Secondary

MeasureTime frame
Limb motor function: Wolf motor function score, Fugl Meyer motor function score;Evaluation of limb spasticity: Modified Ashworth score (MAS);Body balance: Berg Balance Scale;Ability of daily living (behavior): common combination of international classification of functioning, disability and health (ICF);Electrophysiological examination of the affected upper limb;Functional magnetic resonance imaging;

Countries

China

Contacts

Public ContactDongsheng Xu

Yueyang Hospital of Intergrated Tradition Chinese and Western Medicine Shanghai University of Traditional Chinese Medicine

dxu0927@163.com+86 13017103619

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026